Medical Journals In Drug Resistant|OMICS International|Translational Medicine

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Medical Journals In Drug Resistant

OMICS Group International is an open access online publishing group which has 700+ peer-reviewed journals, organizes 3000+ International Scientific Conferences per year, have around 50,000+ editorial board members and 1000+ Scientific associations. Medical Journals provide a platform for outstanding research around the globe in the field of medicine. These scholarly journals aim to contribute to the progress and application of scientific discoveries, by providing free access to the research information. The published work reaches the general public and the scientific community immediately after publication, thus providing higher citation rates for the author. Medical Journals are supported by 5000 internationally renowned editorial board members and a high quality review board. Medical Journals use online Editorial Manager System for quick and high quality review process. Articles of Medical journals are subjected to peer reviewing and these are included in the standard indexing databases like ISI, Scopus, EBSCO, CAS, HINARI etc. All the articles published in Medical journals are permanently archived in respective peer reviewed journals thus providing unrestricted utilization and requisition of the scientific information. Despite the availability of highly efficacious treatment for decades, tuberculosis (TB) remains a major global health problem and ever increasing. Drug-resistant and multidrug-resistant (MDR-TB); resistant to at least isoniazid [INH] and rifampin [RMP]) strains of Mycobacterium tuberculosis are man-made problems mainly related to poor case management and lack of quality drugs. The prevalence of MDR and/or RMP resistance among newly suspected and previously treated cases was 16.9% and 18.3% respectively which is higher than Ethiopian drug resistance survey 2005 (DRS-2005) that reported 1.6 and 12% among new and retreatment TB cases respectively. This might be difference in time that, now due to natural selection, resistance strains are increasing than before and also due to difference in study population that DRS 2005 of Ethiopia were done among smear positive TB patients unlike our study which was done among MDR-TB suspected patients making our study prevalence higher. Multidrug-resistant -TB was found to be significantly associated with HIV seropositive patients having 32% rate when compared to HIV seronegative rate of 2.2%. (Daniel MekonnenNigus, WondemagegnMuluLingerew, BayehAberaBeyene, AschalewAdmassuTamiru, Martha Tibebu Lemma and MulatYimerMelaku, Prevalence of Multi Drug Resistant Tuberculosis among Presumptive Multi Drug Resistant Tuberculosis Cases in Amhara National Regional State, Ethiopia)
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021